The University of Melbourne Centre for Cancer Research

A new grant from the National Cancer Institute will help researchers with the Genetics and Epidemiology of Colorectal Cancer Consortium, or GECCO, better understand the body’s natural immune response to colorectal cancer and what, exactly, drives it.

Six researchers from the University of Melbourne Centre for Cancer Research have been awarded NHMRC Investigator Grants to improve cancer screening and outcomes, to the value of over $11.3 million.The Hon Greg Hunt MP, Minister for Health, announced a total of almost $400 million investment in health and medical research projects, with 237 new projects to receive funding from the National Health and Medical Research Council (NHMRC), and 30 grants to be funded through the Medical Research Future Fund (MRFF) Priority Round.

Researchers at the University of Melbourne Centre for Cancer Research (UMCCR) have established a reliable, scalable and fast bioinformatics platform to analyse the genomic data of hundreds of cancer patients.

New research has captured the seven characteristics of cancer nursing expertise, helping inform and support professional development for these vital roles and improve patient outcomes.

A study to genetically sequence patients with challenging cancers has received almost $5 million funding from the Australian Government’s Medical Research Future Fund Genomics Health Futures Mission to provide a clearer diagnosis and guidance for targeted, personalised treatment options.

In the two years since its establishment, Professor Maarten IJzerman's Cancer Health Services Research group has developed strong programs in data-driven research, cancer registries, precision oncology and clinical trials.

Some countries are reporting a 40 per cent decline in cancer cases at the peak of the pandemic indicating people may be presenting later with symptoms or not attending for cancer screening; people need to see their GP early as possible so hospitals can prioritise capacity to see patients with life-threatening or potentially curative disease.

Researchers at the University of Melbourne Centre for Cancer Research have identified evidence gaps and a lack of consistency in approaches adopted by health economic evaluations of metastatic colorectal cancer treatments.

Researchers at the University of Melbourne Centre for Cancer Research have tested an experimental model aiming to identify new drug targets for rare but highly heritable tumours of the nervous system.

A new initiative from the Department of Clinical Pathology is bringing Honours students and consumer representatives together to highlight the importance of consumer engagement and why it is vital at all levels of research.

Traditional clinical trials have been vital for improving cancer treatments for the last 70 years, but new data-driven approaches can enhance treatment for individuals and better allocate healthcare resources for everyone.

A new philanthropic gift  – the Landerer Fellowship – is providing opportunities for collaboration between the University of Melbourne Centre for Cancer Research and French cancer research laboratories.

Precision medicine is taking us from a one-size-fits-all approach to using patient-specific information—including genomics, clinical and administrative data—to guide healthcare decisions tailored to a specific patient. It is driving improved outcomes through access to more effective treatments earlier, therefore reducing economic and health service burdens.

A new study has identified and characterized the contribution of a protein complex to tumour progression and metastasis in colorectal cancer.

Associate Professor Aung Ko Win, of our Precision Prevention and Early Detection of Colorectal Cancer group, has been named Fellow of the American Gastroenterological Association (AGA), a medical society dedicated to disorders of the gastrointestinal (GI) tract.

A new study to improve colorectal cancer prevention for people with Lynch syndrome  has received funding from Cancer Council Victoria; led by researchers based at the University of Melbourne Centre for Cancer Research (UMCCR).

A study published in the Australasian Journal of Dermatology has found that the use of an electronic survey undertaken in GP waiting rooms is a practical way to identify patients at increased risk of melanoma, informing a more personalised and targeted approach to screening.

Mapping the human genome is revolutionising medicine. The aim? To turn cancer into a manageable, chronic disease like diabetes.

More than 1000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.

The University of Melbourne Centre for Cancer Research (UMCCR) is delighted to welcome Professors Sarah-Jane and Mark Dawson to our group of university leaders committed to improving outcomes for people affected by cancer.